APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nicergoline

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Nicergoline Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025192 pages

Choose your research edition.

Industry ResearchNicergoline Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Nicergoline Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Nicergoline Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nicergoline Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Nicergoline Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Nicergoline market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Nicergoline is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nicergoline is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nicergoline is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nicergoline is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nicergoline include Shandong Qidu Pharmaceutical Co. Ltd., Shandong Fangming Pharmaceutical Group Co. Ltd., Pfizer Pharmaceutical Co., Ltd., Hebei Lingding Biotechnology Co., Ltd., Hainan Zambon Pharmaceutical Co. Ltd, Hainan General Kangli Pharmaceutical Co. Ltd., Hainan Poly Pharm Co. Ltd, Fengchen and Tocris Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nicergoline market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nicergoline and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nicergoline sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nicergoline market size, projected growth trends, production technologies, key applications, and end-use industries.

Nicergoline Segment by Company

Shandong Qidu Pharmaceutical Co. Ltd.

Shandong Fangming Pharmaceutical Group Co. Ltd.

Pfizer Pharmaceutical Co., Ltd.

Hebei Lingding Biotechnology Co., Ltd.

Hainan Zambon Pharmaceutical Co. Ltd

Hainan General Kangli Pharmaceutical Co. Ltd.

Hainan Poly Pharm Co. Ltd

Fengchen

Tocris Bioscience

Teva API

Solarium Pharmaceuticals

Selleck Chemicals

Pharmacia

Olon Group

LGC

Kunshan Rotam Reddy Pharmaceutical Co. Ltd.

Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd.

FAREVA

DEAFARMA

Nicergoline Segment by Type

For Injection

For Oral

Nicergoline Segment by Application

Alzheimer's Disease (AD)

Arterial Hypertension

Cerebral Thrombosis

Others

Nicergoline Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicergoline market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nicergoline and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicergoline.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nicergoline market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nicergoline manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Nicergoline in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Nicergoline in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Nicergoline Industry Trends Table 2. Nicergoline Industry Drivers Table 3. Nicergoline Industry Opportunities and Challenges Table 4. Nicergoline Industry Restraints Table 5. Global Nicergoline Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Nicergoline Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Nicergoline Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Nicergoline Sales Market Share by Manufacturers Table 9. Global Nicergoline Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Nicergoline Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Nicergoline Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Nicergoline Manufacturers, Product Type & Application Table 13. Global Nicergoline Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Nicergoline by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of For Injection Table 17. Major Manufacturers of For Oral Table 18. Global Nicergoline Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Nicergoline Sales by Type (2021-2026) & (K Units) Table 20. Global Nicergoline Sales by Type (2027-2032) & (K Units) Table 21. Global Nicergoline Sales Market Share by Type (2021-2026) Table 22. Global Nicergoline Sales Market Share by Type (2027-2032) Table 23. Global Nicergoline Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Nicergoline Revenue by Type (2021-2026) & (K Units) Table 25. Global Nicergoline Revenue by Type (2027-2032) & (K Units) Table 26. Global Nicergoline Revenue Market Share by Type (2021-2026) Table 27. Global Nicergoline Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Alzheimer's Disease (AD) Table 29. Major Manufacturers of Arterial Hypertension Table 30. Major Manufacturers of Cerebral Thrombosis Table 31. Major Manufacturers of Others Table 32. Global Nicergoline Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Nicergoline Sales by Application (2021-2026) & (K Units) Table 34. Global Nicergoline Sales by Application (2027-2032) & (K Units) Table 35. Global Nicergoline Sales Market Share by Application (2021-2026) Table 36. Global Nicergoline Sales Market Share by Application (2027-2032) Table 37. Global Nicergoline Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Nicergoline Revenue by Application (2021-2026) & (K Units) Table 39. Global Nicergoline Revenue by Application (2027-2032) & (K Units) Table 40. Global Nicergoline Revenue Market Share by Application (2021-2026) Table 41. Global Nicergoline Revenue Market Share by Application (2027-2032) Table 42. Global Nicergoline Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Nicergoline Sales by Region (2021-2026) & (K Units) Table 44. Global Nicergoline Sales Market Share by Region (2021-2026) Table 45. Global Nicergoline Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Nicergoline Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Nicergoline Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Nicergoline Sales by Country (2021-2026) & (K Units) Table 49. North America Nicergoline Sales by Country (2027-2032) & (K Units) Table 50. Europe Nicergoline Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Nicergoline Sales by Country (2021-2026) & (K Units) Table 52. Europe Nicergoline Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Nicergoline Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Nicergoline Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Nicergoline Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Nicergoline Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Nicergoline Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Nicergoline Sales by Country (2027-2032) & (K Units) Table 59. Global Nicergoline Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Nicergoline Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Nicergoline Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Nicergoline Revenue Market Share by Region (2021-2026) Table 63. Global Nicergoline Revenue Market Share by Region (2027-2032) Table 64. Shandong Qidu Pharmaceutical Co. Ltd. Company Information Table 65. Shandong Qidu Pharmaceutical Co. Ltd. Business Overview Table 66. Shandong Qidu Pharmaceutical Co. Ltd. Nicergoline Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Shandong Qidu Pharmaceutical Co. Ltd. Nicergoline Product Portfolio Table 68. Shandong Qidu Pharmaceutical Co. Ltd. Recent Development Table 69. Shandong Fangming Pharmaceutical Group Co. Ltd. Company Information Table 70. Shandong Fangming Pharmaceutical Group Co. Ltd. Business Overview Table 71. Shandong Fangming Pharmaceutical Group Co. Ltd. Nicergoline Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Shandong Fangming Pharmaceutical Group Co. Ltd. Nicergoline Product Portfolio Table 73. Shandong Fangming Pharmaceutical Group Co. Ltd. Recent Development Table 74. Pfizer Pharmaceutical Co., Ltd. Company Information Table 75. Pfizer Pharmaceutical Co., Ltd. Business Overview Table 76. Pfizer Pharmaceutical Co., Ltd. Nicergoline Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Pfizer Pharmaceutical Co., Ltd. Nicergoline Product Portfolio Table 78. Pfizer Pharmaceutical Co., Ltd. Recent Development Table 79. Hebei Lingding Biotechnology Co., Ltd. Company Information Table 80. Hebei Lingding Biotechnology Co., Ltd. Business Overview Table 81. Hebei Lingding Biotechnology Co., Ltd. Nicergoline Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Hebei Lingding Biotechnology Co., Ltd. Nicergoline Product Portfolio Table 83. Hebei Lingding Biotechnology Co., Ltd. Recent Development Table 84. Hainan Zambon Pharmaceutical Co. Ltd Company Information Table 85. Hainan Zambon Pharmaceutical Co. Ltd Business Overview Table 86. Hainan Zambon Pharmaceutical Co. Ltd Nicergoline Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Hainan Zambon Pharmaceutical Co. Ltd Nicergoline Product Portfolio Table 88. Hainan Zambon Pharmaceutical Co. Ltd Recent Development Table 89. Hainan General Kangli Pharmaceutical Co. Ltd. Company Information Table 90. Hainan General Kangli Pharmaceutical Co. Ltd. Business Overview Table 91. Hainan General Kangli Pharmaceutical Co. Ltd. Nicergoline Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Hainan General Kangli Pharmaceutical Co. Ltd. Nicergoline Product Portfolio Table 93. Hainan General Kangli Pharmaceutical Co. Ltd. Recent Development Table 94. Hainan Poly Pharm Co. Ltd Company Information Table 95. Hainan Poly Pharm Co. Ltd Business Overview Table 96. Hainan Poly Pharm Co. Ltd Nicergoline Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Hainan Poly Pharm Co. Ltd Nicergoline Product Portfolio Table 98. Hainan Poly Pharm Co. Ltd Recent Development Table 99. Fengchen Company Information Table 100. Fengchen Business Overview Table 101. Fengchen Nicergoline Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Fengchen Nicergoline Product Portfolio Table 103. Fengchen Recent Development Table 104. Tocris Bioscience Company Information Table 105. Tocris Bioscience Business Overview Table 106. Tocris Bioscience Nicergoline Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Tocris Bioscience Nicergoline Product Portfolio Table 108. Tocris Bioscience Recent Development Table 109. Teva API Company Information Table 110. Teva API Business Overview Table 111. Teva API Nicergoline Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Teva API Nicergoline Product Portfolio Table 113. Teva API Recent Development Table 114. Solarium Pharmaceuticals Company Information Table 115. Solarium Pharmaceuticals Business Overview Table 116. Solarium Pharmaceuticals Nicergoline Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Solarium Pharmaceuticals Nicergoline Product Portfolio Table 118. Solarium Pharmaceuticals Recent Development Table 119. Selleck Chemicals Company Information Table 120. Selleck Chemicals Business Overview Table 121. Selleck Chemicals Nicergoline Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Selleck Chemicals Nicergoline Product Portfolio Table 123. Selleck Chemicals Recent Development Table 124. Pharmacia Company Information Table 125. Pharmacia Business Overview Table 126. Pharmacia Nicergoline Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Pharmacia Nicergoline Product Portfolio Table 128. Pharmacia Recent Development Table 129. Olon Group Company Information Table 130. Olon Group Business Overview Table 131. Olon Group Nicergoline Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Olon Group Nicergoline Product Portfolio Table 133. Olon Group Recent Development Table 134. LGC Company Information Table 135. LGC Business Overview Table 136. LGC Nicergoline Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. LGC Nicergoline Product Portfolio Table 138. LGC Recent Development Table 139. Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Company Information Table 140. Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Business Overview Table 141. Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Nicergoline Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Nicergoline Product Portfolio Table 143. Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Recent Development Table 144. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Company Information Table 145. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Business Overview Table 146. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Nicergoline Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Nicergoline Product Portfolio Table 148. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Recent Development Table 149. FAREVA Company Information Table 150. FAREVA Business Overview Table 151. FAREVA Nicergoline Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. FAREVA Nicergoline Product Portfolio Table 153. FAREVA Recent Development Table 154. DEAFARMA Company Information Table 155. DEAFARMA Business Overview Table 156. DEAFARMA Nicergoline Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. DEAFARMA Nicergoline Product Portfolio Table 158. DEAFARMA Recent Development Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Nicergoline Distributors List Table 162. Nicergoline Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Nicergoline Product Image Figure 2. Global Nicergoline Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nicergoline Market Size (2021-2032) & (US$ Million) Figure 4. Global Nicergoline Sales (2021-2032) & (K Units) Figure 5. Global Nicergoline Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Nicergoline Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. For Injection Image Figure 9. For Oral Image Figure 10. Global Nicergoline Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Nicergoline Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Nicergoline Sales Market Share by Type (2021-2032) Figure 13. Global Nicergoline Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Nicergoline Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Nicergoline Revenue Market Share by Type (2021-2032) Figure 16. Alzheimer's Disease (AD) Image Figure 17. Arterial Hypertension Image Figure 18. Cerebral Thrombosis Image Figure 19. Others Image Figure 20. Global Nicergoline Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Nicergoline Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Nicergoline Sales Market Share by Application (2021-2032) Figure 23. Global Nicergoline Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Nicergoline Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Nicergoline Revenue Market Share by Application (2021-2032) Figure 26. North America Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Nicergoline Sales Market Share by Country (2021-2032) Figure 28. U.S. Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Nicergoline Sales Market Share by Country (2021-2032) Figure 33. Germany Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Nicergoline Sales Market Share by Country (2021-2032) Figure 40. China Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Nicergoline Sales Market Share by Country (2021-2032) Figure 48. Brazil Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Nicergoline Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Nicergoline Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Nicergoline Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Nicergoline Revenue (2021-2032) & (US$ Million) Figure 59. North America Nicergoline Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Nicergoline Revenue (2021-2032) & (US$ Million) Figure 61. Europe Nicergoline Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Nicergoline Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Nicergoline Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Nicergoline Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Nicergoline Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Nicergoline Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Nicergoline Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • For Injection
  • For Oral
Applications
  • Alzheimer's Disease (AD)
  • Arterial Hypertension
  • Cerebral Thrombosis
  • Others
Companies covered
  • Shandong Qidu Pharmaceutical Co. Ltd.
  • Shandong Fangming Pharmaceutical Group Co. Ltd.
  • Pfizer Pharmaceutical Co., Ltd.
  • Hebei Lingding Biotechnology Co., Ltd.
  • Hainan Zambon Pharmaceutical Co. Ltd
  • Hainan General Kangli Pharmaceutical Co. Ltd.
  • Hainan Poly Pharm Co. Ltd
  • Fengchen
  • Tocris Bioscience
  • Teva API
  • Solarium Pharmaceuticals
  • Selleck Chemicals
  • Pharmacia
  • Olon Group
  • LGC
  • Kunshan Rotam Reddy Pharmaceutical Co. Ltd.
  • Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd.
  • FAREVA
  • DEAFARMA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nicergoline Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nicergoline Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Nicergoline Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Nicergoline Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Nicergoline Market Dynamics
  1. 2.1 Nicergoline Industry Trends
  2. 2.2 Nicergoline Industry Drivers
  3. 2.3 Nicergoline Industry Opportunities and Challenges
  4. 2.4 Nicergoline Industry Restraints
3 Nicergoline Market by Manufacturers
  1. 3.1 Global Nicergoline Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Nicergoline Sales by Manufacturers (2021-2026)
  3. 3.3 Global Nicergoline Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Nicergoline Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nicergoline Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Nicergoline Manufacturers, Product Type & Application
  7. 3.7 Global Nicergoline Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nicergoline Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nicergoline Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nicergoline Tier 1, Tier 2, and Tier 3
4 Nicergoline Market by Type
  1. 4.1 Nicergoline Type Introduction
  2. 4.1.1 For Injection
  3. 4.1.2 For Oral
  4. 4.2 Global Nicergoline Sales by Type
  5. 4.2.1 Global Nicergoline Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nicergoline Sales by Type (2021-2032)
  7. 4.2.3 Global Nicergoline Sales Market Share by Type (2021-2032)
  8. 4.3 Global Nicergoline Revenue by Type
  9. 4.3.1 Global Nicergoline Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Nicergoline Revenue by Type (2021-2032)
  11. 4.3.3 Global Nicergoline Revenue Market Share by Type (2021-2032)
5 Nicergoline Market by Application
  1. 5.1 Nicergoline Application Introduction
  2. 5.1.1 Alzheimer's Disease (AD)
  3. 5.1.2 Arterial Hypertension
  4. 5.1.3 Cerebral Thrombosis
  5. 5.1.4 Others
  6. 5.2 Global Nicergoline Sales by Application
  7. 5.2.1 Global Nicergoline Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Nicergoline Sales by Application (2021-2032)
  9. 5.2.3 Global Nicergoline Sales Market Share by Application (2021-2032)
  10. 5.3 Global Nicergoline Revenue by Application
  11. 5.3.1 Global Nicergoline Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Nicergoline Revenue by Application (2021-2032)
  13. 5.3.3 Global Nicergoline Revenue Market Share by Application (2021-2032)
6 Global Nicergoline Sales by Region
  1. 6.1 Global Nicergoline Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nicergoline Sales by Region (2021-2032)
  3. 6.2.1 Global Nicergoline Sales by Region (2021-2026)
  4. 6.2.2 Global Nicergoline Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nicergoline Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Nicergoline Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Nicergoline Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Nicergoline Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Nicergoline Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Nicergoline Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Nicergoline Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Nicergoline Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Nicergoline Revenue by Region
  1. 7.1 Global Nicergoline Revenue by Region
  2. 7.1.1 Global Nicergoline Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Nicergoline Revenue by Region (2021-2026)
  4. 7.1.3 Global Nicergoline Revenue by Region (2027-2032)
  5. 7.1.4 Global Nicergoline Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Nicergoline Revenue (2021-2032)
  8. 7.2.2 North America Nicergoline Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Nicergoline Revenue (2021-2032)
  11. 7.3.2 Europe Nicergoline Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Nicergoline Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Nicergoline Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Nicergoline Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Nicergoline Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Shandong Qidu Pharmaceutical Co. Ltd.
  2. 8.1.1 Shandong Qidu Pharmaceutical Co. Ltd. Company Information
  3. 8.1.2 Shandong Qidu Pharmaceutical Co. Ltd. Business Overview
  4. 8.1.3 Shandong Qidu Pharmaceutical Co. Ltd. Nicergoline Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shandong Qidu Pharmaceutical Co. Ltd. Nicergoline Product Portfolio
  6. 8.1.5 Shandong Qidu Pharmaceutical Co. Ltd. Recent Developments
  7. 8.2 Shandong Fangming Pharmaceutical Group Co. Ltd.
  8. 8.2.1 Shandong Fangming Pharmaceutical Group Co. Ltd. Company Information
  9. 8.2.2 Shandong Fangming Pharmaceutical Group Co. Ltd. Business Overview
  10. 8.2.3 Shandong Fangming Pharmaceutical Group Co. Ltd. Nicergoline Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shandong Fangming Pharmaceutical Group Co. Ltd. Nicergoline Product Portfolio
  12. 8.2.5 Shandong Fangming Pharmaceutical Group Co. Ltd. Recent Developments
  13. 8.3 Pfizer Pharmaceutical Co., Ltd.
  14. 8.3.1 Pfizer Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Pfizer Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Pfizer Pharmaceutical Co., Ltd. Nicergoline Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Pharmaceutical Co., Ltd. Nicergoline Product Portfolio
  18. 8.3.5 Pfizer Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Hebei Lingding Biotechnology Co., Ltd.
  20. 8.4.1 Hebei Lingding Biotechnology Co., Ltd. Company Information
  21. 8.4.2 Hebei Lingding Biotechnology Co., Ltd. Business Overview
  22. 8.4.3 Hebei Lingding Biotechnology Co., Ltd. Nicergoline Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hebei Lingding Biotechnology Co., Ltd. Nicergoline Product Portfolio
  24. 8.4.5 Hebei Lingding Biotechnology Co., Ltd. Recent Developments
  25. 8.5 Hainan Zambon Pharmaceutical Co. Ltd
  26. 8.5.1 Hainan Zambon Pharmaceutical Co. Ltd Company Information
  27. 8.5.2 Hainan Zambon Pharmaceutical Co. Ltd Business Overview
  28. 8.5.3 Hainan Zambon Pharmaceutical Co. Ltd Nicergoline Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hainan Zambon Pharmaceutical Co. Ltd Nicergoline Product Portfolio
  30. 8.5.5 Hainan Zambon Pharmaceutical Co. Ltd Recent Developments
  31. 8.6 Hainan General Kangli Pharmaceutical Co. Ltd.
  32. 8.6.1 Hainan General Kangli Pharmaceutical Co. Ltd. Company Information
  33. 8.6.2 Hainan General Kangli Pharmaceutical Co. Ltd. Business Overview
  34. 8.6.3 Hainan General Kangli Pharmaceutical Co. Ltd. Nicergoline Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hainan General Kangli Pharmaceutical Co. Ltd. Nicergoline Product Portfolio
  36. 8.6.5 Hainan General Kangli Pharmaceutical Co. Ltd. Recent Developments
  37. 8.7 Hainan Poly Pharm Co. Ltd
  38. 8.7.1 Hainan Poly Pharm Co. Ltd Company Information
  39. 8.7.2 Hainan Poly Pharm Co. Ltd Business Overview
  40. 8.7.3 Hainan Poly Pharm Co. Ltd Nicergoline Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hainan Poly Pharm Co. Ltd Nicergoline Product Portfolio
  42. 8.7.5 Hainan Poly Pharm Co. Ltd Recent Developments
  43. 8.8 Fengchen
  44. 8.8.1 Fengchen Company Information
  45. 8.8.2 Fengchen Business Overview
  46. 8.8.3 Fengchen Nicergoline Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Fengchen Nicergoline Product Portfolio
  48. 8.8.5 Fengchen Recent Developments
  49. 8.9 Tocris Bioscience
  50. 8.9.1 Tocris Bioscience Company Information
  51. 8.9.2 Tocris Bioscience Business Overview
  52. 8.9.3 Tocris Bioscience Nicergoline Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Tocris Bioscience Nicergoline Product Portfolio
  54. 8.9.5 Tocris Bioscience Recent Developments
  55. 8.10 Teva API
  56. 8.10.1 Teva API Company Information
  57. 8.10.2 Teva API Business Overview
  58. 8.10.3 Teva API Nicergoline Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Teva API Nicergoline Product Portfolio
  60. 8.10.5 Teva API Recent Developments
  61. 8.11 Solarium Pharmaceuticals
  62. 8.11.1 Solarium Pharmaceuticals Company Information
  63. 8.11.2 Solarium Pharmaceuticals Business Overview
  64. 8.11.3 Solarium Pharmaceuticals Nicergoline Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Solarium Pharmaceuticals Nicergoline Product Portfolio
  66. 8.11.5 Solarium Pharmaceuticals Recent Developments
  67. 8.12 Selleck Chemicals
  68. 8.12.1 Selleck Chemicals Company Information
  69. 8.12.2 Selleck Chemicals Business Overview
  70. 8.12.3 Selleck Chemicals Nicergoline Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Selleck Chemicals Nicergoline Product Portfolio
  72. 8.12.5 Selleck Chemicals Recent Developments
  73. 8.13 Pharmacia
  74. 8.13.1 Pharmacia Company Information
  75. 8.13.2 Pharmacia Business Overview
  76. 8.13.3 Pharmacia Nicergoline Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Pharmacia Nicergoline Product Portfolio
  78. 8.13.5 Pharmacia Recent Developments
  79. 8.14 Olon Group
  80. 8.14.1 Olon Group Company Information
  81. 8.14.2 Olon Group Business Overview
  82. 8.14.3 Olon Group Nicergoline Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Olon Group Nicergoline Product Portfolio
  84. 8.14.5 Olon Group Recent Developments
  85. 8.15 LGC
  86. 8.15.1 LGC Company Information
  87. 8.15.2 LGC Business Overview
  88. 8.15.3 LGC Nicergoline Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 LGC Nicergoline Product Portfolio
  90. 8.15.5 LGC Recent Developments
  91. 8.16 Kunshan Rotam Reddy Pharmaceutical Co. Ltd.
  92. 8.16.1 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Company Information
  93. 8.16.2 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Business Overview
  94. 8.16.3 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Nicergoline Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Nicergoline Product Portfolio
  96. 8.16.5 Kunshan Rotam Reddy Pharmaceutical Co. Ltd. Recent Developments
  97. 8.17 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd.
  98. 8.17.1 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Company Information
  99. 8.17.2 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Business Overview
  100. 8.17.3 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Nicergoline Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Nicergoline Product Portfolio
  102. 8.17.5 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. Ltd. Recent Developments
  103. 8.18 FAREVA
  104. 8.18.1 FAREVA Company Information
  105. 8.18.2 FAREVA Business Overview
  106. 8.18.3 FAREVA Nicergoline Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 FAREVA Nicergoline Product Portfolio
  108. 8.18.5 FAREVA Recent Developments
  109. 8.19 DEAFARMA
  110. 8.19.1 DEAFARMA Company Information
  111. 8.19.2 DEAFARMA Business Overview
  112. 8.19.3 DEAFARMA Nicergoline Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 DEAFARMA Nicergoline Product Portfolio
  114. 8.19.5 DEAFARMA Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nicergoline Value Chain Analysis
  2. 9.1.1 Nicergoline Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nicergoline Production Mode & Process
  6. 9.2 Nicergoline Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nicergoline Distributors
  9. 9.2.3 Nicergoline Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst